Indication

Pulmonary emphysema

Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD). Read more about Pulmonary emphysema

51 drugs 40 manufacturers

Advertisement

Drugs that treat it

Common Pulmonary emphysema therapies.

Showing 10–18 of 51 drugs

Filter & compare in the drug finder →Opens the drug finder with Pulmonary emphysema preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pulmonary emphysema.

Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD).

Pathophysiologically, it is characterized by the irreversible enlargement of the air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls and a loss of lung elastic recoil.

This destruction impairs alveolar capillary gas exchange and leads to dynamic air trapping and lung hyperinflation.

Clinically, affected individuals present with persistent, exertional dyspnea, wheezing, reduced exercise tolerance, and a chronic cough, frequently arising from long-term tobacco smoke exposure or environmental irritants, as well as genetic conditions such as alpha-1 antitrypsin deficiency.

Personalize your experience

Follow Pulmonary emphysema and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it